The Board of Alltracel Pharmaceuticals Plc., (“Alltracel”, or “the Company”), (AIM:AP.L), the Healthcare Innovation Group focused on the Wound Care, Oral Care and Cardiovascular Health markets, are pleased to announce today the appointment of Mr. Nick Hart as CFO and executive director to the Board. His role will focus primarily on corporate activities including mergers and acquisitions. Nick will be based at the Company’s London offices.
